DJIA 17,949.59 -85.34 -0.47%
NASDAQ 5,014.10 19.50 0.39%
S&P 500 2,097.29 -3.11 -0.15%
market minute promo

Incyte Corp (NASDAQ: INCY)

109.19 3.68 (3.48%)

REAL-TIME: Last trade at

Extended Hours: $109.19 $0.00 (0.00%)
Quote as of (NASDAQ)



company name or ticker

Recent Quotes

INCY $109.19 3.48%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $106.76
Previous Close $105.51
Daily Range $104.73 - $109.89
52-Week Range $43.44 - $109.89
Market Cap $18.8B
P/E Ratio -363.83
Dividend (Yield) $0.00 (0.0%)
Volume 1,350,979
Average Daily Volume 1,217,649
Current FY EPS -$0.26

Sector

Healthcare

Industry

Drug Makers

Incyte Corp (INCY) Description

The Company is a drug discovery and development company focused on developing proprietary small molecule drugs to treat serious unmet medical needs. Website: http://www.incyte.com/

News & Commentary

10 Largest Companies by Market Cap in Biotech

The bigger they are, the harder they climb? How the biggest biotechs are booming.

Biotech Investors: May 29th Could Be A Big Day

CAR-T Therapy Stocks Hit Hard Following AACR Data

It's A Big Weekend For Biotech

Incyte Describes Emerging Development Pipeline Related to Eleven Abstracts at AACR

Monday's ETF Movers: XBI, GDXJ

Incyte (INCY) Is Strong On High Volume Today

The Reason Behind Geron Corporation's 25% Catapult Higher in March

A favorable fourth-quarter earnings report and an even more favorable view from one Wall Street firm set the stage for a great March for Geron. But, can the good times keep rolling?

Stock Index Tracking Red-Hot Cancer Immunotherapy Field Launched

16 Biotech Catalysts SunTrust Is Tracking

See More INCY News...

INCY's Top Competitors

INCY $109.19 (3.48%)
Current stock: INCY
AMGN $168.46 (1.50%)
Current stock: AMGN
GILD $105.20 (4.52%)
Current stock: GILD
BIIB $422.11 (-0.19%)
Current stock: BIIB